4th Tumor Myeloid Targeting Therapies Summit 2024
Evvnt Promotion / evvnt
11.06.2024 - 13.06.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Kongressthemen
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2219781-3?pid=4832
Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
Brochure: https://go.evvnt.com/2219781-3?pid=4832
Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2219781-2?pid=4832
Herr Luke Kelly
Onkologie
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."